Posts

FDA panel strongly backs Moderna's mRNA flu vaccine for older adults, with final decision expected by early August 2026.

on

Enanta Presses Ahead with RSV Drug Zelicapavir Despite Missing Primary Endpoint in Phase IIb Trial

on

Veru Survey Highlights Muscle Loss Concerns Among GLP-1 Users as Lean Mass-Preserving Drug Advances

on

EU Lifts Restriction on Valneva's Chikungunya Vaccine for Older Adults, Recommends Caution

on

FDA Approves Moderna’s Next-Generation Covid Vaccine With Limited Use for Most Healthy People

on

FDA Institutes Stricter, Targeted COVID Vaccine Policy, Moving Away from 'One-Size-Fits-All' Approach

on

FDA Approves Novavax COVID Vaccine After Delay, Limits Use to Smaller High-Risk Population

on

FDA, CDC call for pause of chikungunya shot rollout in older adults

on

France pauses chikungunya vaccinations in the elderly after patient death

on